Takeda’s Flagship Product Panitumumab (PAN)+mFOLFOX6 Ve... Takeda’s Flagship Product Panitumumab (PAN)+mFOLFOX6 Versus bevacizumab (BE... havensmith  3 years ago
Junshi’s domestic Toripalimab’s significant results in... Junshi’s domestic Toripalimab’s significant results in recurrent or metasta... havensmith  3 years ago